85 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

2142

HBM Holdings
HK$2.4115.9%41.8%HK$1.8bn/aPE10.6xn/an/a

6998

Genor Biopharma Holdings
HK$1.892.2%76.6%HK$976.2mn/aPS63.5xn/an/a

1530

3SBio
HK$5.69-3.7%-14.0%HK$13.4bHK$8.29PE7.6xE16.5%4.2%

570

China Traditional Chinese Medicine Holdings
HK$2.12-5.4%-35.0%HK$10.7bHK$2.60PE11xS4.8%n/a

1558

YiChang HEC ChangJiang Pharmaceutical
HK$9.633.2%0.3%HK$8.5bHK$12.59PE4.8xS-1.2%0%

2161

JBM (Healthcare)
HK$1.72-9.5%63.8%HK$1.4bn/aPE8.5xn/a6.4%

1681

Consun Pharmaceutical Group
HK$7.60-4.5%53.5%HK$6.3bHK$10.20PE7.1xE14.7%7.6%

6622

Zhaoke Ophthalmology
HK$1.311.6%-55.4%HK$715.4mHK$2.50PS11.8xE11.7%n/a

1643

Modern Chinese Medicine Group
HK$0.32-11.1%-8.6%HK$192.0mn/aPE12.6xn/a0%

2137

Brii Biosciences
HK$1.0911.2%-49.3%HK$797.0mHK$1.00PS19.6xE-7.4%n/a

719

Shandong Xinhua Pharmaceutical
HK$5.54-7.5%-1.8%HK$9.0bn/aPE7.9xn/a1.0%

1061

Essex Bio-Technology
HK$2.78-2.8%11.2%HK$1.6bHK$5.12PE6xE6.2%4.3%

897

Wai Yuen Tong Medicine Holdings
HK$0.2918.0%-25.3%HK$331.9mn/aPE160.2xn/a10.2%

1167

Jacobio Pharmaceuticals Group
HK$1.303.2%-62.0%HK$1.0bHK$3.70PS41.7xS-2.4%n/a

1672

Ascletis Pharma
HK$2.86-8.9%108.8%HK$2.8bHK$1.99PS258.4xE-7.1%n/a

1312

Kontafarma China Holdings
HK$0.0316.9%-16.2%HK$173.2mn/aPS0.2xn/a0%

6996

Antengene
HK$0.71-1.4%-58.7%HK$482.4mHK$1.65PS8.1xE17.0%n/a

2511

HighTide Therapeutics
HK$1.08-2.7%-90.9%HK$556.0mn/aPB1xn/an/a

8225

China Health Group
HK$0.201.0%26.3%HK$196.1mn/aPS7.5xn/an/a

512

Grand Pharmaceutical Group
HK$4.43-3.7%14.5%HK$15.5bHK$6.63PE6.4xE2.3%5.9%

2633

Jacobson Pharma
HK$1.010%68.3%HK$2.0bn/aPE7.9xn/a6.9%

1349

Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
HK$2.18-6.0%-11.0%HK$6.1bn/aPE20.2xn/a1.9%

2096

Simcere Pharmaceutical Group
HK$6.56-5.1%5.1%HK$16.3bHK$8.93PS2.4xE75.4%2.6%

867

China Medical System Holdings
HK$7.14-0.4%-44.4%HK$17.3bHK$10.78PE11.7xE21.4%5.8%
Page 1 of 4